Choosing a local anesthetic is not always simple. Many factors will influence the choice of pain control such as procedure type and patient history, to name a few. Most clinicians will usually favour around 1 or 2 local anesthetic they are comfortable with. It is common for a clinician have 1-2 local anesthetics onsite with a vasoconstrictor and one type of anesthetic without vasoconstrictor, for patients with heart conditions. The local anesthetic choice is typically dependent on various aspects, including what was used while studying in university, what has been used in previous practices or what their colleagues are currently using. In a study on local anesthetics used by dentists in Ontario, it was concluded that lidocaine 1:100,000 and articaine 1:200,000 are most commonly used.1
HANSAmed Limited was the first company to distribute the original articaine, Ultracaine, in Canada. Because of this, we pride ourselves. With Ultracaine, dentists are seeing exactly what is expected: predictability, safety, and efficacy.
With indications of infiltration anesthesia and nerve block anesthesia, Ultracaine has been clinically proven to be effective. Ultracaine has a high lipid solubility which allows the anesthetic to diffuse through tissue better and faster than any other anesthetic drug on the market.
Ultracaine D-S and D-S Forte have both a high plasma protein binding rate in addition to a high lipid solubility. The rapid breakdown of articaine to the inactive metabolite articanic acid is related to a very low systemic toxicity and consequently to the possibility of repeated injections.2
With so many pain control options available in the field of dentistry, it can be daunting to begin the process of choosing the right one. Although, with Ultracaine, the benefits listed above are evident. With choosing Ultracaine, you can be rest assured that your local anesthetic predictable, safe and efficacious.
- Gaffen, A. S., & Haas, D. A. (2009). Survey of local anesthetic use by Ontario dentists. Journal of Canadian Dental Association, 75(9), 649.
- Oertel, R., Rahn, R., & Kirch, W. (1997). Clinical pharmacokinetics of articaine. Clinical Pharmacokinetics, 33(6), 417-425. doi: 10.2165/00003088-1997-33060-00002.